Betekenis van:
academia

Voorbeeldzinnen

1. continued awareness-raising of the Convention’s prohibitions throughout Government, industry, academia and non-governmental organisations,
2. Transnational regional consortia will mobilise and associate research actors in academia, industry and government to deliver ‘guidance’ solutions with and for technologically less developed regions.
3. The enhancement of industry-academia cooperation in terms of research training, career development and knowledge sharing, taking into account the protection of intellectual property rights, is encouraged throughout the ‘Marie Curie Actions’, while a dedicated action is addressing industry-academia pathways and partnerships, with special attention being given to SMEs.
4. Means to realise this include in particular academia-industry collaborations — collaborative or contract research conducted or funded jointly with the private sector — licensing and the creation of spin-offs.
5. Close cooperation between the European Community and the Industry and other stakeholders, such as regulatory agencies, patients, academia, clinicians, etc., will be ensured, as well as the mobilisation of public and private funds.
6. The High Level Group should bring together representatives of the Commission, Member States, European Parliament and relevant stakeholders notably industry and civil society, inter alia, consumers, trade unions, NGOs and research/academia.
7. Result 3 — national authorities and relevant national and international partners, the chemical industry, academia and the OPCW are able to improve synergies and further contacts towards a common goal — the full and effective implementation of the Convention.
8. Pre-competitive research, as defined through the Strategic Research Agenda (SRA) of the Innovative Medicines Initiative will include: development of tools and methods to better predict the suitability, safety and efficacy of drugs, intelligent infrastructures for data integration and knowledge management through close cooperation between industry, academia and clinical centres at all necessary steps.
9. The group should be composed of representatives of the Commission, the Member States, the European Parliament and relevant stakeholders notably from the chemicals industry and downstream users, as well as civil society, to be drawn, inter alia, from representatives of consumers, trade unions, non-governmental organisations and research/academia.